I would certainly hope that the government would see fit to at least put in a basic safeguard so that none of the advisory boards shall have appointed to them anyone who has a financial interest in a pharmaceutical company or a medical devices company. It is common sense.
One of my colleagues mentioned Bill C-91. That nightmare surfaces again. We all know how powerful the pharmaceutical lobby is already. We certainly do not need it infiltrating the boards of our medical research institutes.